TNF and rheumatoid arthritis: Three tumor necrosis factor-alpha inhibitor (TNFi) drugs, etanercept, adalimumab, and infliximab, which are commonly prescribed for patients with RA, psoriatic arthritis, spondyloarthritis, and inflammatory bowel disease, are among the top 10 drugs with the highest costs in the US.